NCT04064801

Brief Summary

The study aimed to investigate the association between RDW and in-hospital mortality in methanol poisoning.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 20, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 22, 2019

Completed
7 months until next milestone

Study Start

First participant enrolled

March 15, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2020

Completed
Last Updated

April 15, 2021

Status Verified

April 1, 2021

Enrollment Period

3 months

First QC Date

August 20, 2019

Last Update Submit

April 12, 2021

Conditions

Keywords

Alcohol, red blood cell distribution width, methanol poisoning, prognosis

Outcome Measures

Primary Outcomes (2)

  • Hospital mortality

    7 day

  • Need for mechanical ventilation

    7 day

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with acute methanol toxicity who were diagnosed and treated at the Adana City Training and Research Hospital

You may qualify if:

  • All patients aged ≥18 years who were admitted to emergency departments from January 2019 to January 2020 on account of acute methanol intoxication.

You may not qualify if:

  • Incomplete data, Malignancy, Severe anaemia, History of erythrocyte transfusion last 6 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Adana City Training and Research Hospital

Adana, 01170, Turkey (Türkiye)

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adana City Training and Research Hospital

Study Record Dates

First Submitted

August 20, 2019

First Posted

August 22, 2019

Study Start

March 15, 2020

Primary Completion

May 30, 2020

Study Completion

August 30, 2020

Last Updated

April 15, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations